Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: Results from the Gram-Positive Cocci Resistance Surveillance program (2005-2010)

Diagnostic Microbiology and Infectious Disease

Volumn 73, Issue 2, 2012, Pages 174-181

  Zhao, Chunjiang ^a   Sun, Hongli ^b   Wang, Hui ^a   Liu, Yudong ^b,m   Hu, Bijie ^c   Yu, Yunsong ^d,n   Sun, Ziyong ^e   Chu, Yunzhuo ^f   Cao, Bin ^g   Liao, Kang ^h   Lei, Jin'e ⁱ   Hu, Zhidong ^j   Zhang, Liyan ^k   Zhang, Xiaobing ^l   Xu, Yingchun ^b   Wang, Zhanwei ^a   Chen, Minjun ^b  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c FUDAN UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY   (China)

^e HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^f CHINA MEDICAL UNIVERSITY   (China)

^g CAPITAL MEDICAL UNIVERSITY   (China)

^h THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

ⁱ THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^j TIANJIN MEDICAL UNIVERSITY   (China)

^k GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^l SOUTHWEST HOSPITAL   (China)

^m UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁿ ZHEJIANG UNIVERSITY   (China)

more..

Author keywords

Methicillin resistant Staphylococcus aureus (MRSA); Penicillin resistant S. pneumoniae; Resistance surveillance programs; Vancomycin resistant enterococci

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CEFACLOR; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; OXACILLIN; PENICILLIN G; PENICILLIN V; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN;

AGAR DILUTION; AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CHINA; CLINICAL STUDY; COAGULASE NEGATIVE STAPHYLOCOCCUS; GRAM POSITIVE BACTERIUM; GRAM POSITIVE COCCI RESISTANCE SURVEILLANCE PROGRAM; HOSPITAL PATIENT; HUMAN; METHICILLIN RESISTANT COAGULASE NEGATIVE STAPHYLOCOCCUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTPATIENT; PENICILLIN RESISTANT STREPTOCOCCUS PNEUMONIAE; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TEACHING HOSPITAL; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; CHINA; DRUG RESISTANCE, BACTERIAL; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALS, TEACHING; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; PUBLIC HEALTH SURVEILLANCE;

EID: 84861200072     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.03.003     Document Type: Article

References (25)

1. Aspa J., Rajas O., Castro F.R.D. Pneumococcal antimicrobial resistance: therapeutic strategy and management in community-acquired pneumoniae. Expert Opin Pharmacother 2008, 9:229-241. Expert Opin Pharmacother, 9, 229-241.
2. Clinical and Laboratory Standards Institute (CLSI) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard 2009, M7-A8, CLSI, Wayne, PA. 8th ed.
3. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. M100-S21 2011, CLSI, Wayne, PA.
4. Hawser S.P., Bouchillon S.K., Hoban D.J., Dowzicky M., Babinchak T. Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009. Int J Antimicrob Agents 2011, 37:219-224.
5. Hermsen E.D., Shull S.S., Mitropoulos I.F., Puumala S.E., Rupp M.E. Prospective evaluation of clinical and economic outcomes associated with treatment of serious infections due to Gram-positive cocci. Infect Dis Clin Pract 2009, 17:17-21.
6. Hodes D.S., Sudol T.E. Relative sensitivities of streptococcus pneumoniae strains to penicillin and ceftriaxone. J Clin Microbiol 2001, 39:4597-4608.
7. Ho P., Lo P., Chow K., Lau E., Lai E., Cheng V., et al. Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong. J Infect 2010, 60:140-145.
8. Kehrmann J., Kaase M., Szabados F., Gatermann S., Buer J., Rath P.M., et al. Vancomycin MIC creep in MRSA blood culture isolates from Germany: a regional problem?. Eur J Clin Microbiol Infect Dis 2011, 30:677-683.
9. King M.D., Humphrey B.J., Wang Y.F., Kourbatova E.V., Ray S.M., Blumberg H.M. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 2006, 144:309-317.
10. Kronvall G., Karlsson I., Walder M., Sörberg M., Nilsson L.E. Epidemiological MIC cut-off values for tigecycline calculated from Etest MIC values using normalized resistance interpretation. J Antimicrob Chemother 2006, 57:498-505.
11. Linden P.K., Pasculle A.W., Manez R., Kramer D.J., Fung J.J., Pinna A.D., et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 1996, 22:663-670.
12. Liu Y., Wang H., Chen M., Sun Z., Zhao R., Zhang L., et al. Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from children in China younger than 5 years. Diagn Microbiol Infect Dis 2008, 61:256-263.
13. Louie J., Jean C., Chen T.H., Park S., Ueki R., Harper T., et al. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza a (H1N1)-United States, May-August 2009 (Reprinted from MMWR, vol 58, pg 1071-1074, 2009). JAMA-J Am Med Assoc 2009, 302:1852-1862.
14. Patel R., Uhl J.R., Kohner P., Hopkins M.K., Cockerill F.R. Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci. J Clin Microbiol 1997, 35:703-707.
15. Patricia A.B. Tigecycline: a first in class glycylcycline. Clin Microbiol Newsl 2004, 26:163-168.
16. Pfaller M.A., Sader H.S., Jones R.N. Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005). Diagn Microbiol Infect Dis 2007, 57:459-465.
17. Ray A.J., Pultz N.J., Bhalla A., Aron D.C., Donskey C.J. Coexistence of vancomycin-resistant enterococci and staphylococcus aureus in the intestinal tracts of hospitalized patients. Clin Infect Dis 2003, 37:875-881.
18. Reik R., Tenover F.C., Klein E., McDonald L.C. The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004. Diagn Microbiol Infect Dis 2008, 62:81-85.
19. Sader H.S., Jones R.N. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008). Diagn Microbiol Infect Dis 2009, 65:158-162.
20. Sader H.S., Moet G.J., Jones R.N. Antimicrobial resistance among gram-positive bacteria isolated in Latin American hospitals. J Chemother 2009, 21:611-620.
21. Steinkraus G., White R., Friedrich L. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. J Antimicrob Chemother 2007, 60:788-794.
22. Sun W., Chen H., Liu Y., Zhao C., Nichols W.W., Chen M., et al. Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China. Antimicrob Agents Chemother 2009, 53:3642-3649.
23. Van Bambeke F., Reinert R.R., Appelbaum P.C., Tulkens P.M., Peetermans W.E. Multidrug-resistant streptococcus pneumoniae infections: current and future therapeutic options. Drugs 2007, 67:2355-2382.
24. Yao K., Wang L., Zhao G., Zheng Y., Deng L., Huang J., et al. Pneumococcal serotype distribution and antimicrobial resistance in Chinese children hospitalized for pneumonia. Vaccine 2011, 29:2296-2301.
25. Zhen W., Bin C., Ying-mei L., Li G., Chen W. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study. Chin Med J 2009, 122:1283-1288.